These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 28674521)
1. Ghrelin Is a Regulator of Glucagon-Like Peptide 1 Secretion and Transcription in Mice. Lindqvist A; Shcherbina L; Fischer AT; Wierup N Front Endocrinol (Lausanne); 2017; 8():135. PubMed ID: 28674521 [TBL] [Abstract][Full Text] [Related]
2. On the role of the gut in diabetic hyperglucagonaemia. Lund A Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385175 [TBL] [Abstract][Full Text] [Related]
3. Ghrelin Is a Novel Regulator of GLP-1 Secretion. Gagnon J; Baggio LL; Drucker DJ; Brubaker PL Diabetes; 2015 May; 64(5):1513-21. PubMed ID: 25412624 [TBL] [Abstract][Full Text] [Related]
4. The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes. Lund A; Vilsbøll T; Bagger JI; Holst JJ; Knop FK Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1038-46. PubMed ID: 21386059 [TBL] [Abstract][Full Text] [Related]
5. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations. Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405 [TBL] [Abstract][Full Text] [Related]
6. Dissociated effects of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide-1 on beta-cell secretion and insulin clearance in mice. Pacini G; Thomaseth K; Ahrén B Metabolism; 2010 Jul; 59(7):988-92. PubMed ID: 20153002 [TBL] [Abstract][Full Text] [Related]
10. [Secretion of incretin hormones in people having risk factors for type 2 diabetes mellitus]. Shestakova EA; Il'in AV; Shestakova MV; Dedov II Ter Arkh; 2014; 86(10):10-4. PubMed ID: 25509885 [TBL] [Abstract][Full Text] [Related]
11. Activation of proglucagon gene transcription by protein kinase-A in a novel mouse enteroendocrine cell line. Drucker DJ; Jin T; Asa SL; Young TA; Brubaker PL Mol Endocrinol; 1994 Dec; 8(12):1646-55. PubMed ID: 7535893 [TBL] [Abstract][Full Text] [Related]
12. Regulation of glucagon-like peptide-1 synthesis and secretion in the GLUTag enteroendocrine cell line. Brubaker PL; Schloos J; Drucker DJ Endocrinology; 1998 Oct; 139(10):4108-14. PubMed ID: 9751489 [TBL] [Abstract][Full Text] [Related]
13. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP. Theodorakis MJ; Carlson O; Michopoulos S; Doyle ME; Juhaszova M; Petraki K; Egan JM Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E550-9. PubMed ID: 16219666 [TBL] [Abstract][Full Text] [Related]
14. Effect of GIP, GLP-1, insulin and gastrin on ghrelin release in the isolated rat stomach. Lippl F; Kircher F; Erdmann J; Allescher HD; Schusdziarra V Regul Pept; 2004 Jun; 119(1-2):93-8. PubMed ID: 15093702 [TBL] [Abstract][Full Text] [Related]
15. Glucagon-like-peptide-1 secretion from canine L-cells is increased by glucose-dependent-insulinotropic peptide but unaffected by glucose. Damholt AB; Buchan AM; Kofod H Endocrinology; 1998 Apr; 139(4):2085-91. PubMed ID: 9528997 [TBL] [Abstract][Full Text] [Related]
16. Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery. Svane MS; Bojsen-Møller KN; Nielsen S; Jørgensen NB; Dirksen C; Bendtsen F; Kristiansen VB; Hartmann B; Holst JJ; Madsbad S Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E505-14. PubMed ID: 26786780 [TBL] [Abstract][Full Text] [Related]
17. Coregulation of glucagon-like peptide-1 synthesis with proglucagon and prohormone convertase 1 gene expression in enteroendocrine GLUTag cells. Dhanvantari S; Izzo A; Jansen E; Brubaker PL Endocrinology; 2001 Jan; 142(1):37-42. PubMed ID: 11145564 [TBL] [Abstract][Full Text] [Related]
18. Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes. Nauck MA; El-Ouaghlidi A; Gabrys B; Hücking K; Holst JJ; Deacon CF; Gallwitz B; Schmidt WE; Meier JJ Regul Pept; 2004 Nov; 122(3):209-17. PubMed ID: 15491793 [TBL] [Abstract][Full Text] [Related]
19. Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men. Matikainen N; Björnson E; Söderlund S; Borén C; Eliasson B; Pietiläinen KH; Bogl LH; Hakkarainen A; Lundbom N; Rivellese A; Riccardi G; Després JP; Alméras N; Holst JJ; Deacon CF; Borén J; Taskinen MR PLoS One; 2016; 11(1):e0145890. PubMed ID: 26752550 [TBL] [Abstract][Full Text] [Related]
20. Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), gastric inhibitory polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resections. Nauck MA; Siemsglüss J; Orskov C; Holst JJ Z Gastroenterol; 1996 Mar; 34(3):159-66. PubMed ID: 8650968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]